The fight against cancer hinges on timely detection and treatment of tumors that multiply rapidly. The scientific community is focusing on innovations like liquid biopsies, which can detect tumor traces in blood, significantly changing patient treatment and prognosis. Rafael Lopez, a leading oncologist, notes that while there are still technical and economic hurdles to overcome, liquid biopsy represents a profound shift in oncology, doubling survival rates and providing crucial insights into patient tumors through simple blood tests. He believes future advancements are on the horizon as these challenges are addressed.
It is an important innovation because it makes us change the way we treat and give a prognosis to patients.
During this time he has seen oncology move into another world: from little more than chemotherapy to treat a handful of tumors with a dismal prognosis, to having a complex therapeutic arsenal that has managed to double cancer survival.
For the patient, this blood test is like a blood sample for a conventional analysis, but it can reveal invaluable information about a tumor.
Solving these obstacles is only a matter of time.
Collection
[
|
...
]